dc.contributor.author | Whinnett, Zachary I | |
dc.contributor.author | Sohaib, S M Afzal | |
dc.contributor.author | Jones, Siana | |
dc.contributor.author | Kyriacou, Andreas | |
dc.contributor.author | March, Katherine | |
dc.contributor.author | Coady, Emma | |
dc.contributor.author | Mayet, Jamil | |
dc.contributor.author | Hughes, Alun D | |
dc.contributor.author | Frenneaux, Michael | |
dc.contributor.author | Francis, Darrel P | |
dc.contributor.author | BRAVO Investigators | |
dc.date.accessioned | 2014-12-18T10:31:01Z | |
dc.date.available | 2014-12-18T10:31:01Z | |
dc.date.issued | 2014-04-03 | |
dc.identifier.citation | Whinnett , Z I , Sohaib , S M A , Jones , S , Kyriacou , A , March , K , Coady , E , Mayet , J , Hughes , A D , Frenneaux , M , Francis , D P & BRAVO Investigators 2014 , ' British randomised controlled trial of AV and VV optimization ("BRAVO") study : rationale, design, and endpoints ' , BMC Cardiovascular Disorders , vol. 14 , 42 . https://doi.org/10.1186/1471-2261-14-42 | en |
dc.identifier.other | PURE: 45254353 | |
dc.identifier.other | PURE UUID: a85c11b5-a136-448e-9cd8-41df3bf56f52 | |
dc.identifier.other | PubMed: 24693953 | |
dc.identifier.other | Scopus: 84897964065 | |
dc.identifier.uri | http://hdl.handle.net/2164/4113 | |
dc.language.iso | eng | |
dc.relation.ispartof | BMC Cardiovascular Disorders | en |
dc.rights | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | en |
dc.subject | Biological Markers | en |
dc.subject | Blood Pressure Determination | en |
dc.subject | Cardiac Resynchronization Therapy | en |
dc.subject | Cardiac Resynchronization Therapy Devices | en |
dc.subject | Clinical Protocols | en |
dc.subject | Cross-Over Studies | en |
dc.subject | Echocardiography, Doppler | en |
dc.subject | Exercise Test | en |
dc.subject | Exercise Tolerance | en |
dc.subject | Great Britain | en |
dc.subject | Heart Failure | en |
dc.subject | Hemodynamics | en |
dc.subject | Humans | en |
dc.subject | Natriuretic Peptide, Brain | en |
dc.subject | Peptide Fragments | en |
dc.subject | Photoplethysmography | en |
dc.subject | Predictive Value of Tests | en |
dc.subject | Quality of Life | en |
dc.subject | Questionnaires | en |
dc.subject | Recovery of Function | en |
dc.subject | Research Design | en |
dc.subject | Time Factors | en |
dc.subject | Treatment Outcome | en |
dc.subject | Ventricular Function, Left | en |
dc.subject | Ventricular Remodeling | en |
dc.subject | Optimization | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | British randomised controlled trial of AV and VV optimization ("BRAVO") study : rationale, design, and endpoints | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1186/1471-2261-14-42 | |
dc.identifier.vol | 14 | en |